IMU-935

IMU-935 – Target RORγt

The IMU-935 program comprises one lead compound and a family of orally available small molecule inhibitors of RORγt.
RORγt is a nuclear receptor responsible for gene expression of important cytokines which are involved in various immune or autoimmune diseases.

 

IMU-366